Press release
Anti-Infective Agents Market Size is Projected to Reach US$ 195.8 Billion by 2035 With a CAGR of 2.6% | Fact.MR
Anti-Infective Agents Market
The steady increase in antimicrobial resistance, combined with a growing infectious disease burden across the globe, is serving as a key driver for long-term demand. Besides that, growing government and private investment in developing antibiotics, particularly in emerging and developing economies, is promoting sustainable development in the global pharma sector.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8045
Market Analysis
The industry is developing steadily, driven by worldwide AMR needs, ramped-up R&D spendings, and high-priority anti-infectives regulation by authorities. Regional players and pharma innovators benefit, with low-margin generics threatened by escalating price and compliance pressure.
Country-wise Analysis
The U.S. market for anti-infective agents will expand at a 6.8% CAGR over the forecast period. The widespread incidence of infectious diseases, global prevalence of antimicrobial resistance, and ongoing demand for new anti-infective therapy propel growth. The U.S. pharma industry has one of the most sophisticated pharma environments in terms of high R&D investment.
The UK anti-infective agents market will have a 5.9% CAGR over the study period. Government-supported surveillance programs and infection control strategies are the backbone of the UK anti-infective agents market growth.
The German anti-infective agents market will witness a growth at 6.0% CAGR over the study period. A well-established healthcare infrastructure, robust healthcare spending, and robust pharmaceutical R&D capabilities fuel the growth.
The Chinese market for anti-infective agents is predicted to rise at 7.4% CAGR over the forecast period. China is experiencing accelerated healthcare evolution with government investment, urbanization, and increasing middle-class demographics with access to quality healthcare. The nation has stepped up nationwide campaigns against the abuse of antibiotics and the sale of antibiotics over the counter, with stricter regulatory oversight of anti-infective drug distribution.
Segment-wise Analsysis
By Type :
By 2025, the market for anti-infective agents will be led by the antiviral segment, which will hold the largest 51% market share compared to antibacterial agents' 30%. Evidently, the trend reflects the global world's healthcare priorities as viral threats persistently emerge and re-emerge, impacting public health systems.
By Range :
By type, broad-spectrum agents dominate the market for anti-infective agents with a 60% market share compared to the other 40% market share of narrow-spectrum agents. This pattern confirms the ongoing preference by clinicians towards therapeutics, which provides broad activity against a spectrum of pathogens, particularly when in the context of acute and empiric treatment.
Competitive Outlook
Anti-infective agents market is extensive and competitive where global pharmaceuticals giants are betting on broad-spectrum antibiotics together with antiviral and antifungal therapeutics. Large R&D pipeline, regulatory milestones, and symbiotic strategic collaborative partnerships with biotech firms, the major stalwarts are GlaxoSmithKline, Pfizer, and Bayer AG.
Sanofi, Merck Co. and Bristol-Myers Squibb form a robust industry presence with future-generation anti-infectives, such as combination therapies that employ new mechanisms targeting resistant pathogens. These firms are enhancing their drug portfolios through strategic acquisitions and licensing deals, expanding their portfolios in infectious disease treatment.
Abbott, Novartis, and Johnson and Johnson have actually concentrated their investments in antiviral innovation, such as creating therapies for HIV and hepatitis C, and expanded their penetration across the globe by partnering with public health entities and governments in expanding access to their critical medicines, as well as better investment in developing diagnostics, vaccines, and precision medicine strategies. These heightened cases of incurability of multi-drug-resistant infection have prompted these firms to invest more in rapid diagnostics, vaccines, and precision medicine strategies.
Browse Full Report: https://www.factmr.com/report/anti-infective-agents-market
Key Players
GlaxoSmithKline plc.
Pfizer Inc.
Bayer AG
Sanofi
Merck & Co., Inc.
Bristol-Myers Squibb Company
Abbott
Novartis AG
Johnson & Johnson Services Inc.
Gilead Sciences, Inc.
Astellas Pharma Inc.
Segmentation
By Type :
Antiviral
Antibacterial
Antifungal
Others
By Range :
Narrow Spectrum
Broad Spectrum
By Route of Administration :
IV
Oral
Topical
Others
By Indication :
HIV
Tuberculosis
Respiratory Infection
Pneumonia
Others
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
E-Commerce
Others
By Region :
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)
Check out More Related Studies Published by Fact.MR:
Breathalyzer Market
https://www.factmr.com/report/125/breathalyzer-market
Radiotherapy Devices Market
https://www.factmr.com/report/77/radiotherapy-devices-market
Cardiac POC Testing Devices Market
https://www.factmr.com/report/cardiac-poc-testing-devices-market
Kidney Dialysis Equipment and Supplies Market
https://www.factmr.com/report/kidney-dialysis-equipment-and-supplies-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Infective Agents Market Size is Projected to Reach US$ 195.8 Billion by 2035 With a CAGR of 2.6% | Fact.MR here
News-ID: 3977239 • Views: …
More Releases from Fact.MR
Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need…
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in…
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising…
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035.
The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
[CAGR of 5.5%] Silica Flour Market Size, CAGR, Competitive Analysis and Forecast …
The global silica flour industry generated $520.0 million in 2021, and is estimated to reach $876.3 million by 2031, witnessing a CAGR of 5.5% from 2022 to 2031.
Allied Market Research published a report, titled, "Silica Flour Market by Type (Quartz, Cristobalite), by Application (Fiberglass, Glass and Clay, Oil Well Cement, Ceramic and Refractory, Foundry, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." The report offers a detailed analysis…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Call Center AI Market Latest, CAGR, Volume and Value 2022-2030 | (CAGR) of 25%
New York , United States- Report Ocean published the latest research report on the Call Center AI market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, business cycles, and microeconomic requirements that pertain precisely to the market under study. In addition, the Call Center AI market study demonstrates a detailed examination of the business state, which represents creative ways for company growth,…
